Friday, April 24, 2026
33 C
Bengaluru

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

With over nine years at the organization and more than 25 years of experience in the pharmaceutical industry, he brings deep insight into how innovation and focused sales and marketing strategies can drive meaningful improvements in patient outcomes.

In his new role, he will lead the company’s core “One Gynaec” mission. By aligning its specialized divisions, Akumentis Healthcare aims to build a unified, high-impact ecosystem dedicated to gynaecology and infertility. He will be steering the organization toward scaling new milestones, introducing transformative products, and strengthening its position within the Indian pharmaceutical landscape.

He also expressed his gratitude to Executive Director Mr. Kanishk Jain, CEO Mr. Ajay Dhiman, along with mentors, colleagues, and the broader healthcare community for their continued trust and support.

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img